Whalegun
Home

Regeneron Pharmaceuticals REGN spent $610K on lobbying in Q2 2025 · Health Issues, Medicare and 3 more issues

Trade details

Type
Lobbying report
Amount
$610,000
Quarter
Q2 2025
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
25/07/21

Up 52.5% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN spent $610K on lobbying in Q2 2025 · Health Issues, Medicare and 3 more issues | Whalegun